247 related articles for article (PubMed ID: 29982174)
21. Revisiting the Ethics of Research on Human Subjects.
Tsay C
AMA J Ethics; 2015 Dec; 17(12):1105-7. PubMed ID: 27086370
[No Abstract] [Full Text] [Related]
22. An analysis of common ethical justifications for compassionate use programs for experimental drugs.
Raus K
BMC Med Ethics; 2016 Oct; 17(1):60. PubMed ID: 27756370
[TBL] [Abstract][Full Text] [Related]
23. Compassionate use of gene therapies in pediatrics: An ethical analysis.
Neuhaus CP; Zacharias RL
Semin Perinatol; 2018 Dec; 42(8):508-514. PubMed ID: 30389228
[TBL] [Abstract][Full Text] [Related]
24. Access to 'investigational' cancer drugs: perspective of a trainee.
Kuo JC
Intern Med J; 2015 Feb; 45(2):235. PubMed ID: 25650544
[No Abstract] [Full Text] [Related]
25. What do patients with unmet medical needs want? A qualitative study of patients' views and experiences with expanded access to unapproved, investigational treatments in the Netherlands.
Bunnik EM; Aarts N
BMC Med Ethics; 2019 Nov; 20(1):80. PubMed ID: 31706313
[TBL] [Abstract][Full Text] [Related]
26. Ethics review in compassionate use.
Borysowski J; Ehni HJ; Górski A
BMC Med; 2017 Jul; 15(1):136. PubMed ID: 28735571
[TBL] [Abstract][Full Text] [Related]
27. Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits.
Fountzilas E; Said R; Tsimberidou AM
Expert Opin Investig Drugs; 2018 Feb; 27(2):155-162. PubMed ID: 29353505
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic uses of investigational drugs: research extension, compassionate use, and expanded access].
Goldim JR
Rev Panam Salud Publica; 2008 Mar; 23(3):198-206. PubMed ID: 18397586
[TBL] [Abstract][Full Text] [Related]
29. Legal and ethical obligations to conduct a clinical drug trial in Australia as an investigator initiated and sponsored study for an overseas pharmaceutical company.
Beran RG
Med Law; 2004; 23(4):913-24. PubMed ID: 15685926
[TBL] [Abstract][Full Text] [Related]
30. An ethical framework for the creation, governance and evaluation of accelerated access programs.
Pace J; Ghinea N; Kerridge I; Lipworth W
Health Policy; 2018 Sep; 122(9):984-990. PubMed ID: 30055901
[TBL] [Abstract][Full Text] [Related]
31. Six-year activity on approval of compassionate use of medicines by the Ethics Committee of the University Hospital of Bologna (Italy): time to update rules and recommendations.
Montanaro N; Melis M; Proni S; Chiabrando G; Motola D
Eur J Clin Pharmacol; 2017 Apr; 73(4):479-485. PubMed ID: 28035436
[TBL] [Abstract][Full Text] [Related]
32. Implementation of 21st Century Cures Act Expanded Access Policies Requirements.
Kang S; Chang S; Ross JS; Miller JE
Clin Pharmacol Ther; 2021 Dec; 110(6):1579-1584. PubMed ID: 34431083
[TBL] [Abstract][Full Text] [Related]
33. Examining the ethics of clinical use of unproven interventions outside of clinical trials during the Ebola epidemic.
Shah SK; Wendler D; Danis M
Am J Bioeth; 2015; 15(4):11-6. PubMed ID: 25856592
[TBL] [Abstract][Full Text] [Related]
34. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
35. Experimental countermeasures against Ebola virus: current progress and an ethical conundrum.
Plummer FA; Wong G; Kobinger GP
CMAJ; 2014 Oct; 186(15):1129-30. PubMed ID: 25139506
[No Abstract] [Full Text] [Related]
36. Medical Innovation in a Children's Hospital: 'Diseases desperate grown by desperate appliance are relieved, or not at all'.
Larcher V; Turnham H; Brierley J
Bioethics; 2018 Jan; 32(1):36-42. PubMed ID: 28873231
[TBL] [Abstract][Full Text] [Related]
37. Ethical allocation of drugs and vaccines in the West African ebola epidemic.
Gostin LO
Milbank Q; 2014 Dec; 92(4):662-6. PubMed ID: 25492601
[No Abstract] [Full Text] [Related]
38. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
[TBL] [Abstract][Full Text] [Related]
39. Expanded Access Allows for Compassionate Use of Investigational Cancer Drugs.
Miller D
ONS Connect; 2015 Jun; 30(2):47. PubMed ID: 26137830
[No Abstract] [Full Text] [Related]
40. Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges.
Hyun I
J Law Med Ethics; 2010; 38(2):277-85. PubMed ID: 20579251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
